Department of Oral & Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirao Preto, University of Sao Paulo
Ribeirão Preto, São Paulo, 14040-904, Brazil
NCT Number: NCT02102360
This clinical study compared a conventional surgical technique (CST) and a minimally invasive surgical technique (MIST) in the regenerative treatment of mandibular furcation defects.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Ribeirão Preto, São Paulo, 14040-904, Brazil
Using a split-mouth design, fifteen patients with bilateral class II and III furcation defects were treated with MIST (Test Group) or CST (Control Group). Furcation defects in both groups were filled with anorganic bovine bone (ABB) and enamel matrix derivative (EMD). Patient-centered outcomes including analyses of pain, discomfort, edema, hematoma, root hypersensitivity and daily activities interference were recorded using a Visual Analogue Scale seven days after surgeries. Clinical and radiographic parameters were assessed at baseline and 6 months postoperatively. Data were statistically analysed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(I) subjects with a diagnosis of periodontitis; (II) presence of one pair of contralateral mandibular molars with buccal / lingual furcation defects; (III) non-smokers; (IV) plaque index < 20%.
Exclusion criteria
(I) patients that presented systemic disease; (II) had taken antibiotics in the past 6 months prior to surgery; (III) pregnant women or lactating mothers; (IV) molars with periapical disease; (V) cervical restorations or prosthesis closer than 1 mm to fornix; (VI) lingual furcation defects presenting gingival recession (GR)
used to improve periodontal regenerative procedures.
Other names: Anorganic Bovine Bone (Bio-Oss, Geistlich Pharma).
used to improve periodontal regenerative procedures.
Other names: Enamel Matrix Derivative (Emdogain - Institute Straumann, Switzerland).
Time frame: baseline and 6 months after surgical procedure
The clinical measure HCAL was assessed and recorded by an experienced periodontist, blinded to the procedures to assess the efficacy of surgical procedures.
Time frame: 7 days after surgery
Time frame: 7 days after surgery
Time frame: 7 days after surgery
Time frame: 7 days after surgery
Time frame: 7 days after surgery
Time frame: 7 days after surgery
Time frame: baseline and 6 months
The clinical measure HCAL was assessed and recorded by an experienced periodontist, blinded to the procedures to assess the efficacy of surgical procedures.
Time frame: baseline and 6 months
The clinical measure HCAL was assessed and recorded by an experienced periodontist, blinded to the procedures to assess the efficacy of surgical procedures
Time frame: baseline and 6 months
The clinical measure HCAL was assessed and recorded by an experienced periodontist, blinded to the procedures to assess the efficacy of surgical procedures
Time frame: baseline and 6 months
The radiographs were obtained with the paralleling technique employing an x-ray unit and a digital sensor . Customized radiographic holders for each patient . Digital subtraction radiographs (DSR) were performed using a specific software. All pairs of baseline and 6-month radiographs for each treated site were then subtracted.
Standardized regions of interest (ROIs) were select for each subtracted digital image: (1) placed in the bone's most coronal and central aspect of the furcation defect; and (2) placed at a distant untreated site acting as a radiographic control. The ROIs were not superimposed on any portion of the tooth surface. A software (Image Tool for Windows, Version 3.0, USA) was used to assess radiographic density changes that occurred in ROIs.
University of Sao Paulo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06757660
Furcation Defects, Mouth Diseases
Minya, Egypt
View Trial DetailsNCT07042204
Furcation Defects, Mouth Diseases
Al Mansurah, Egypt
View Trial DetailsNCT06519409
Furcation Defects, Mouth Diseases
Bengaluru, Karnataka, India
View Trial DetailsNCT04842188
Furcation Defects, Mouth Diseases
Kafr ash Shaykh, Egypt
View Trial Details